|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01715 AI HEALTH TECH
Nominal 
0.570 -0.070 (-10.938%) | 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Turnover | 91,885 | 8.908% | 84,369 | 88,186 | 143,873 | 189,380 |
| Cost of Sales | (85,400) | 35.229% | (63,152) | (49,699) | (78,603) | (94,394) |
| Gross Profit | 6,485 | -69.435% | 21,217 | 38,487 | 65,270 | 94,986 |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (4,024) | -29.589% | (5,715) | (2,059) | (129) | (1,407) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (342) | -39.576% | (566) | (393) | (736) | 4,679 | |
| Profit / (Loss) before Taxation | (35,958) | -27.038% | (49,283) | (43,206) | (43,720) | (19,671) | |
| Taxation | (47) | 34.286% | (35) | (344) | (174) | (279) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 155 | -- | 0 | 337 | (459) | (1,178) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (35,850) | -27.308% | (49,318) | (43,213) | (44,353) | (21,128) | |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 4,157 | -46.034% | 7,703 | 5,002 | 1,419 | 1,912 |
| Depreciation & Amortisation | 4,238 | -23.141% | 5,514 | 7,205 | 6,811 | 7,406 |
| Directors' Emoluments | 662 | -53.282% | 1,417 | 1,502 | 1,441 | 1,429 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified (Modified Report) | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | -32.375 | -49.315% | -63.875 | -63.000 | -64.750 | -30.844 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | (0.364) | -- | 0.216 | (1.265) | (0.007) | (0.013) |
| NBV per share ($) | 0.312 | -- | 0.674 | 1.17196 | 1.812242 | 2.460923 |
| Remarks: | Real time quote last updated: 28/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -11,500 |
| %Change | -50.322% |
| EPS / (LPS) | RMB -0.080 |
| NBV Per Share (¥) | RMB 0.240 |